ZNF79
Zinc finger protein 79
Also known as: pT7, ZNF79_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15937
- Gene
- ZNF79
- Ensembl
- ENSG00000196152
- Chromosome
- 9
- Canonical length
- 498 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
498 residues, UniProt reviewed canonical sequence.
>Q15937|ZNF79
1 MLEEGVLPSP GPALPQEENT GEEGMAAGLL TAGPRGSTFF SSVTVAFAQE RWRCLVSTPR
61 DRFKEGIPGK SRSLVLLGLP VSQPGMNSQL EQREGAWMLE GEDLRSPSPG WKIISGSPPE
121 QALSEASFQD PCVEMPPGDS DHGTSDLEKS FNLRPVLSPQ QRVPVEARPR KCETHTESFK
181 NSEILKPHRA KPYACNECGK AFSYCSSLSQ HQKSHTGEKP YECSECGKAF SQSSSLIQHQ
241 RIHTGEKPYK CSECGRAFSQ NANLTKHQRT HTGEKPYRCS ECEKAFSDCS ALVQHQRIHT
301 GEKPYECSDC GKAFRHSANL TNHQRTHTGE KPYKCSECGK AFSYCAAFIQ HQRIHTGEKP
361 YRCAACGKAF SQSANLTNHQ RTHTGEKPYK CSECGKAFSQ STNLIIHQKT HTGEKPYKCN
421 ECGKFFSESS ALIRHHIIHT GEKPYECNEC GKAFNQSSSL SQHQRIHTGV KPYECSECGK
481 AFRCSSAFVR HQRLHAGELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF79 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 5.8 nTPM
Expression across tissuesHPA
Tissue
- testis: 5.8 nTPM
- thymus: 5.1 nTPM
- urinary bladder: 5 nTPM
- tongue: 4.9 nTPM
- parathyroid gland: 4.6 nTPM
- skeletal muscle: 4.5 nTPM
Single-cell type
- endometrial stromal cells: 23 nCPM
- cardiomyocytes: 20 nCPM
- medullary thymic epithelial cells: 19 nCPM
- myonuclei: 14 nCPM
- late primary spermatocytes: 13 nCPM
- choroid plexus epithelial cells: 12 nCPM
Immune cell
- memory CD8 T-cell: 7.6 nTPM
- NK-cell: 7.2 nTPM
- MAIT T-cell: 6.7 nTPM
- gdT-cell: 6 nTPM
- naive B-cell: 5.8 nTPM
- naive CD8 T-cell: 5.8 nTPM
Brain region
- cerebellum: 16 nTPM
- medulla oblongata: 10 nTPM
- white matter: 9.8 nTPM
- basal ganglia: 9.6 nTPM
- choroid plexus: 9.6 nTPM
- hypothalamus: 9.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.69
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.21
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF79 as an antibody target. Whether an autoantibody or antibody against ZNF79 could matter depends on whether native ZNF79 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF79 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF79 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...